Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration

doi:10.1083/jcb.113.6.1439

This Article

	Full Text (PDF, 814K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Kojima, S.
	Articles by Rifkin, D. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Kojima, S.
	Articles by Rifkin, D. B.


Social Bookmarking

	What's this?

ARTICLES

Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration

S Kojima, PC Harpel and DB Rifkin
Department of Cell Biology, New York University Medical School, New York 10016.

Conditioned medium (CM) derived from co-cultures of bovine aortic endothelial cells (BAECs) and bovine smooth muscle cells (BSMCs) contains transforming growth factor-beta (TGF-beta) formed via a plasmin-dependent activation of latent TGF-beta (LTGF beta), which occurs in heterotypic but not in homotypic cultures (Sato, Y., and D. B. Rifkin. 1989. J. Cell Biol. 107: 1199-1205). The TGF-beta formed is able to block the migration of BSMCs or BAECs. We have found that the simultaneous addition to heterotypic culture medium of plasminogen and the atherogenic lipoprotein, lipoprotein (a) (Lp(a)), which contains plasminogen-like kringles, inhibits the activation of LTGF-beta in a dose-dependent manner. The inclusion of LDL in the culture medium did not show such an effect. Control experiments indicated that Lp(a) does not interfere with the basal level of cell migration, the activity of exogenous added TGF-beta, the release of LTGF-beta from cells, the activation of LTGF-beta either by plasmin or by transient acidification, or the activity of plasminogen activator. The addition of Lp(a) to the culture medium decreased the amount of plasmin found in BAECs/BSMCs cultures. Similar results were obtained using CM derived from cocultures of human umbilical vein endothelial cells and human foreskin fibroblasts. These results suggest that Lp(a) can inhibit the activation of LTGF-beta by competing with the binding of plasminogen to cell or matrix surfaces. Therefore, high plasma levels of Lp(a) might enhance smooth muscle cell migration by decreasing the levels of the migration inhibitor TGF-beta thus contributing to generation of the atheromatous lesions.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Lazo-Langner, A., Knoll, G. A., Wells, P. S., Carson, N., Rodger, M. A. (2006). The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene. Blood 108: 4052-4058 [Abstract] [Full Text]
Shyu, K.-G., Chao, Y.-M., Wang, B.-W., Kuan, P. (2005). Regulation of Discoidin Domain Receptor 2 by Cyclic Mechanical Stretch in Cultured Rat Vascular Smooth Muscle Cells. Hypertension 46: 614-621 [Abstract] [Full Text]
O'Neil, C. H., Boffa, M. B., Hancock, M. A., Pickering, J. G., Koschinsky, M. L. (2004). Stimulation of Vascular Smooth Muscle Cell Proliferation and Migration by Apolipoprotein(a) Is Dependent on Inhibition of Transforming Growth Factor-{beta} Activation and on the Presence of Kringle IV Type 9. J. Biol. Chem. 279: 55187-55195 [Abstract] [Full Text]
Grainger, D. J. (2004). Transforming Growth Factor {beta} and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis. Arterioscler. Thromb. Vasc. Bio. 24: 399-404 [Abstract] [Full Text]
Ruberg, F. L, Loscalzo, J. (2002). Prothrombotic determinants of coronary atherothrombosis. Vasc Med 7: 289-299 [Abstract]
Komai, N., Morishita, R., Yamada, S., Oishi, M., Iguchi, S., Aoki, M., Sasaki, M., Sakurabayashi, I., Higaki, J., Ogihara, T. (2002). Mitogenic Activity of Oxidized Lipoprotein (a) on Human Vascular Smooth Muscle Cells. Hypertension 40: 310-314 [Abstract] [Full Text]
WAHN, F., DANIEL, V., KRONENBERG, F., OPELZ, G., MICHALK, D. V., QUERFELD, U. (2001). Impact of Apolipoprotein(a) Phenotypes on Long-Term Renal Transplant Survival. J. Am. Soc. Nephrol. 12: 1052-1058 [Abstract] [Full Text]
FUJISAWA, M., HARAMAKI, R., MIYAZAKI, H., IMAIZUMI, T., OKUDA, S. (2000). Role of Lipoprotein (a) and TGF-{beta}1 in Atherosclerosis of Hemodialysis Patients. J. Am. Soc. Nephrol. 11: 1889-1895 [Abstract] [Full Text]
Yokota, M., Ichihara, S., Lin, T.-L., Nakashima, N., Yamada, Y. (2000). Association of a T29->C Polymorphism of the Transforming Growth Factor-{beta}1 Gene With Genetic Susceptibility to Myocardial Infarction in Japanese. Circulation 101: 2783-2787 [Abstract] [Full Text]
Draude, G., Lorenz, R. L. (2000). TGF-beta 1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am. J. Physiol. Heart Circ. Physiol. 278: H1042-H1048 [Abstract] [Full Text]
Grainger, D., Mosedale, D., Metcalfe, J., Bottinger, E. (2000). Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions. J. Cell Sci. 113: 2355-2361 [Abstract]
Yang, L., Qiu, C. X., Ludlow, A., Ferguson, M. W. J., Brunner, G. (1999). Active Transforming Growth Factor-� in Wound Repair : Determination Using a New Assay. Am. J. Pathol. 154: 105-111 [Abstract] [Full Text]
Dangas, G., Mehran, R., Harpel, P. C., Sharma, S. K., Marcovina, S. M., Dube, G., Ambrose, J. A., Fallon, J. T. (1998). Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol 32: 2035-2042 [Abstract] [Full Text]
Morishita, R., Yamada, S., Yamamoto, K., Tomita, N., Kida, I., Sakurabayashi, I., Kikuchi, A., Kaneda, Y., Lawn, R., Higaki, J., Ogihara, T. (1998). Novel Therapeutic Strategy for Atherosclerosis : Ribozyme Oligonucleotides Against Apolipoprotein(a) Selectively Inhibit Apolipoprotein(a) But Not Plasminogen Gene Expression. Circulation 98: 1898-1904 [Abstract] [Full Text]
Koglin, J., Glysing-Jensen, T., Raisanen-Sokolowski, A., Russell, M. E. (1998). Immune Sources of Transforming Growth Factor-�1 Reduce Transplant Arteriosclerosis : Insight Derived From a Knockout Mouse Model. Circ. Res. 83: 652-660 [Abstract] [Full Text]
Romanic, A. M., Arleth, A. J., Willette, R. N., Ohlstein, E. H. (1998). Factor XIIIa Cross-links Lipoprotein(a) With Fibrinogen and Is Present in Human Atherosclerotic Lesions. Circ. Res. 83: 264-269 [Abstract] [Full Text]
Morishita, R., Yamada, S., Higaki, J., Tomita, N., Kida, I., Aoki, M., Moriguchi, A., Hayashi, S.-i., Sakurabayashi, I., Kaneda, Y., Ogihara, T. (1998). Conditioned Medium From HepG2 Cells Transfected With Human Apolipoprotein(a) Gene Stimulates Growth of Human Vascular Smooth Muscle Cells : Effects of Overexpression of Human Apolipoprotein(a) Gene. Hypertension 32: 215-222 [Abstract] [Full Text]
Powell, R. J., Bhargava, J., Basson, M. D., Sumpio, B. E. (1998). Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology. Am. J. Physiol. Heart Circ. Physiol. 274: H642-H649 [Abstract] [Full Text]
Hopkins, P. N., Wu, L. L., Hunt, S. C., James, B. C., Vincent, G. M., Williams, R. R. (1997). Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio. 17: 2783-2792 [Abstract] [Full Text]
Kochl, S., Fresser, F., Lobentanz, E., Baier, G., Utermann, G. (1997). Novel Interaction of Apolipoprotein(a) With beta -2 Glycoprotein I Mediated by the Kringle IV Domain. Blood 90: 1482-1489 [Abstract] [Full Text]
Ryan, M. J., Emig, L. L., Hicks, G. W., Ramharack, R., Spahr, M. A., Kreick, J. S., Brammer, D. W., Chien, A. J., Keiser, J. A. (1997). Localization of Lipoprotein(a) in a Monkey Model of Rapid Neointimal Growth. Arterioscler. Thromb. Vasc. Bio. 17: 181-187 [Abstract] [Full Text]
Lawn, R. M., Pearle, A. D., Kunz, L. L., Rubin, E. M., Reckless, J., Metcalfe, J. C., Grainger, D. J. (1996). Feedback Mechanism of Focal Vascular Lesion Formation in Transgenic Apolipoprotein(a) Mice. J. Biol. Chem. 271: 31367-31371 [Abstract] [Full Text]
Cambien, F., Ricard, S., Troesch, A., Mallet, C., Generenaz, L., Evans, A., Arveiler, D., Luc, G., Ruidavets, J.-B., Poirier, O. (1996). Polymorphisms of the Transforming Growth Factor-�1 Gene in Relation to Myocardial Infarction and Blood Pressure: The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28: 881-887 [Abstract] [Full Text]
Okada, S. S., Grobmyer, S. R., Barnathan, E. S. (1996). Contrasting Effects of Plasminogen Activators, Urokinase Receptor, and LDL Receptor�Related Protein on Smooth Muscle Cell Migration and Invasion. Arterioscler. Thromb. Vasc. Bio. 16: 1269-1276 [Abstract] [Full Text]
Mancini, F.P., Newland, D.L., Mooser, V., Murata, J., Marcovina, S., Young, S.G., Hammer, R.E., Sanan, D.A., Hobbs, H.H. (1995). Relative Contributions of Apolipoprotein(a) and Apolipoprotein-B to the Development of Fatty Lesions in the Proximal Aorta of Mice. Arterioscler. Thromb. Vasc. Bio. 15: 1911-1916 [Abstract] [Full Text]
Lawn, R. M., Boonmark, N. W., Schwartz, K., Lindahl, G. E., Wade, D. P., Byrne, C. D., Fong, K. J., Meer, K., Patthy, L. (1995). The Recurring Evolution of Lipoprotein(a). J. Biol. Chem. 270: 24004-24009 [Abstract] [Full Text]
Raghunath, P.N., Tomaszewski, J. E., Brady, S. T., Caron, R. J., Okada, S. S., Barnathan, E. S. (1995). Plasminogen Activator System in Human Coronary Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 15: 1432-1443 [Abstract] [Full Text]
Bendixen, E., Harpel, P. C., Sottrup-Jensen, L. (1995). Location of the Major [IMAGE]-([IMAGE]-Glutamyl)lysyl Cross-linking Site in Transglutaminase-modified Human Plasminogen. J. Biol. Chem. 270: 17929-17933 [Abstract] [Full Text]
Gamble, J. R., Bradley, S., Noack, L., Vadas, M. A. (1995). TGF-� and Endothelial Cells Inhibit VCAM-1 Expression on Human Vascular Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Bio. 15: 949-955 [Abstract] [Full Text]
Kojima, S., Muramatsu, H., Amanuma, H., Muramatsu, T. (1995). Midkine Enhances Fibrinolytic Activity of Bovine Endothelial Cells. J. Biol. Chem. 270: 9590-9596 [Abstract] [Full Text]
Dzau, V. J., Gibbons, G. H., Kobilka, B. K., Lawn, R. M., Pratt, R. E. (1995). Genetic Models of Human Vascular Disease. Circulation 91: 521-531 [Abstract] [Full Text]
Grainger, D., Kirschenlohr, H., Metcalfe, J., Weissberg, P., Wade, D., Lawn, R. (1993). Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 260: 1655-1658 [Abstract]
Klose, R., Fresser, F., Kochl, S., Parson, W., Kapetanopoulos, A., Fruchart-Najib, J., Baier, G., Utermann, G. (2000). Mapping of a Minimal Apolipoprotein(a) Interaction Motif Conserved in Fibrin(ogen) beta - and gamma -Chains. J. Biol. Chem. 275: 38206-38212 [Abstract] [Full Text]